MENU

Can Emerson Electric (EMR) Stock Reach $175?

a developer of process controls systems, valves and analytical instruments

EMR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Sep 02, 2026

Can Emerson Electric (EMR) Stock Reach $175?

Key Takeaways

  • The target: $175 per share, roughly 18% above recent trading levels near $147 and beyond the stock's 52-week high of $166.35.
  • Bullish case: Strong energy, LNG, power, and semiconductor demand, expanding margins, and double-digit software growth support a higher valuation.
  • Bearish case: A premium valuation, exposure to cyclical capital spending, soft refining and European demand, and debt tied to recent acquisitions.
  • Key levels: Resistance sits near the $166 52-week high; support is found near $145–$147, then at the 52-week low of $122.64.
  • Bottom line: $175 is plausible over a 12-to-24-month horizon, but it would require a decisive breakout to a new all-time high.

Why Investors Are Watching $175

Emerson Electric Co. (EMR), the St. Louis–based industrial technology and software company, has traded in a wide range over the past year, between a low of $122.64 and a high of $166.35. The $175 level sits just above that ceiling, making it both a natural psychological milestone and a widely cited analyst price objective. Several Wall Street firms—including Argus Research and BMO Capital Markets—have published $175 targets on the stock, while more bullish desks have set goals of $180 to $205. Reaching $175 would therefore mean more than a routine bounce; it would require the shares to clear their August 2026 peak and establish fresh record territory.

Current Market Position

Emerson has transformed itself from a broad industrial conglomerate into a focused automation and software provider. It divested its climate technologies and consumer businesses and completed the roughly $7.2 billion purchase of the remaining AspenTech stake in 2025, deepening its industrial software footprint following the earlier acquisition of National Instruments. For fiscal 2026, the company reorganized reporting into three segments: Software and Systems, Intelligent Devices, and Safety and Productivity.

Fundamentals remain solid. In its most recent quarterly results, Emerson posted adjusted earnings per share (EPS) of $1.71, ahead of the $1.68 consensus, on revenue of $4.87 billion that also beat estimates. Underlying sales rose 6%, orders grew 7%, and adjusted segment EBITDA margin—a measure of operating profitability—expanded 140 basis points to 28.5%. Annualized recurring software revenue grew 9%, a key metric supporting the company's premium multiple.

What Could Drive the Next Leg Higher

Emerson's growth is increasingly tied to capital-intensive end markets with strong multiyear backlogs. Management has highlighted robust demand across LNG (liquefied natural gas), power generation, pharmaceuticals, semiconductors, and aerospace and defense. Test and measurement orders climbed 19% in the latest quarter, with semiconductor-related activity up roughly 70%. A growing project pipeline—up 8% to about $12.4 billion—provides visibility into future revenue.

Margin expansion is another catalyst. The company is targeting further EBITDA margin improvement, supported by pricing, a favorable mix shift toward software, and cost discipline. Because software revenue carries higher margins than hardware, continued double-digit annual contract value growth could lift overall profitability and, in turn, justify a higher price-to-earnings (P/E) multiple.

What Could Prevent the Move

The primary obstacle is valuation. Even after its recent pullback, Emerson trades at a forward P/E around 20 times earnings, a premium to many diversified industrial peers. That leaves little room for error if growth slows. The company also carries meaningful debt following its AspenTech and National Instruments transactions, and its refinings, upstream energy, and European and Chinese end markets have remained comparatively weak.

Broader cyclical risk matters as well. Much of Emerson's order growth depends on customer capital expenditures in energy and industrial automation. A downturn in those budgets—whether from lower commodity prices, tighter credit, or an economic slowdown—could stall the momentum needed to push the stock to $175.

Analyst Opinions and Price Targets

Wall Street sentiment leans positive, with a consensus "Moderate Buy" or "Buy" rating and an average price target in the $168 to $171 range, according to recent data. Targets span a wide band, from a low of about $104 to a high near $205. Notable recent calls include Bernstein initiating coverage with an outperform rating, Evercore and BNP Paribas setting $185 objectives, and Bank of America maintaining a $191 target. The $175 level therefore sits modestly above the analyst average but comfortably within the range of what many sell-side firms consider fair value.

Technical Levels That Matter

From a technical analysis standpoint, $166.35—the August 2026 high—is the most important resistance level standing between the current price and $175. A sustained move above that point would mark a breakout from the stock's recent range and could open a path toward the target. On the downside, the $145–$147 zone has acted as near-term support, with the 52-week low of $122.64 serving as a deeper floor. Investors watching the $175 price target should treat the $166 zone as the key confirmation level to monitor first.

AI Daily Buy/Sell Signals

Traders seeking a more systematic way to track momentum in names like Emerson can turn to Tickeron's AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. It is designed to help traders spot emerging opportunities, monitor existing positions, and identify changing market trends more efficiently than manual chart review alone. For investors evaluating whether EMR can reach $175, such signals offer a data-driven complement to fundamental and technical research.

Final Assessment

Can Emerson Electric reach $175? The level is ambitious but not unrealistic. The stock would need to climb roughly 18% and break decisively above its $166.35 record high. Supporting that scenario are resilient end-market demand in energy and semiconductors, expanding margins, growing software revenue, and broadly favorable analyst coverage. Working against it are a demanding valuation, heavy debt from recent acquisitions, and exposure to cyclical capital spending that could soften. Investors should watch the $166 breakout level, quarterly order and backlog trends, and margin progression as the clearest signals of whether the path to $175 is opening.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
EMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

EMR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMR
1D Price
Change %
EMR100%
-2.56%
AME - EMR
71%
Closely correlated
-3.40%
IR - EMR
70%
Closely correlated
-1.10%
ROK - EMR
70%
Closely correlated
-2.23%
LECO - EMR
69%
Closely correlated
-0.71%
KMT - EMR
64%
Loosely correlated
-0.07%
More

Groups containing EMR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMR
1D Price
Change %
EMR100%
-2.56%
EMR
(5 stocks)
81%
Closely correlated
-0.08%
Producer Manufacturing
(351 stocks)
14%
Poorly correlated
-0.94%